PTAB Upholds Vimpat Patent In Generic Makers' Challenge
The Patent Trial and Appeal Board upheld a Research Corp. Technologies Inc. patent for the anti-epileptic drug Vimpat on Wednesday, just months after a Delaware federal judge refused to invalidate part...To view the full article, register now.
Already a subscriber? Click here to view full article